Value through Innovation27 July 2016

What is a lay summary?

To view this video in other translations click on the language below:
Chinese (simplified)
Chinese (traditional)
French
German
Italian
Japanese
Portuguese (Brazilian)
Spanish

Clinical Study Results

  • MOBIC ® - Spondylitis, Ankylosing
    Clinical Study Number 107.237
    Study Indication Spondylitis, Ankylosing
    Product MOBIC ®
    Generic Name Meloxicam
    Lab Code
    Clinical Phase IIIb
    Study Title

    A randomized, open label, 3-arm evaluation of efficacy and safety of Meloxicam suppository(15 mg daily) and tablet (15 mg daily) compared to Indomethacin suppository (50 mg daily) in patients with ankylosing spondylitis

    Study Document
    Trial synopsis 107.237 english